Pharma & Biotech

Biotechnology firm Tevogen Bio Holdings is embarking on a significant corporate transformation, centered on a comprehensive overhaul of its executive...

Today's release of BioNTech's full-year 2025 financials is drawing investor attention away from quarterly earnings and toward the company's evolving...

The pharmaceutical sector is bracing for potential margin compression after Novo Nordisk signaled aggressive price reductions for its blockbuster GLP-1...

A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The...

A notable surge in institutional investment is signaling strong market confidence in Gilead Sciences. The biopharmaceutical giant is attracting significant...

Investor attention within the biotechnology space is increasingly focused on Outlook Therapeutics. The company is approaching several pivotal operational milestones...

The medical technology firm Strata Skin Sciences is moving to formally terminate its status as a publicly traded company. This...

Following the full integration of Progressive Care, NextPlat Corp. is expressing confidence in its operational trajectory for the coming periods....

Axsome Therapeutics is entering a pivotal phase of commercial growth, with plans to significantly scale its operations and await a...

The operational journey of Ampio Pharmaceuticals is nearing its conclusion. The company has shifted its focus entirely to executing an...